Stroke During TAVI: An Unmet Clinical Need? - Paragon Conventions

More documents

Recommendations

Info

Results of TAVI are improving • Source • Corevalve 18F • UK registry • Partner trial
Stroke is still a major source of co- morbidity • 2.9%–6.7% of patients undergoing transfemoral TAVI (with both the Edwards SAPIEN or CoreValve device) and 1.8%–5% of patients undergoing transapical TAVI (Edwards SAPIEN).
Page 1 and 2: Stroke During TAVI: An Unmet Clinic
Page 3: Stroke prevention in TAVI: An unmet
Page 9 and 10: The Source Registry
Page 11 and 12: New Perspectives on Stroke During T
Page 13 and 14: Study design Evaluation Clinical an
Page 15 and 16: DW - MRI
Page 17 and 18: NIH-Stroke Score 20 18 16 4 2 0 NIH
Page 19 and 20: What about Transfemoral vs Transapi
Page 21 and 22: DW-MRI Results Post TAVI
Page 23 and 24: Neurological and Cognitive Test Res
Page 25 and 26: Significance of MRI lesions? • No
Page 27 and 28: Mechanisms of Stroke during TAVI -
Page 35 and 36: What can we do stop the shower?
Page 37 and 38: Brachiocephalic trunk Cerebral Filt
Page 39 and 40: Embolic Material
Page 41 and 42: Embrella Embolic Deflector • Poro
Page 43 and 44: Embrella Case Example
Page 45 and 46: Embrella Case Example
Page 47 and 48: Embrella Clinical Experience
Page 49 and 50: Average number of Lesions/Subject
Page 51 and 52: Aortic Embolic Protection Device (
Page 53 and 54: Post TAVI Antiplatelet Therapy •

Stroke During TAVI: An Unmet Clinical Need? - Paragon Conventions

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?